Peri-implantitis Market Research 2025-2030: Analysis of Growth Trends and Leading Competitors, Featuring Pfizer, Cadila Pharmaceuticals, GaronitPharma, Basic Pharma Life Science, Prachi Pharmaceuticals & More
1. The peri-implantitis market is projected to reach $1.75 billion by 2030. 2. Factors include increased periodontitis cases and technological advancements in dental treatments. 3. Surgical methods dominate, with laser debridement seeing the highest expected growth. 4. Europe leads the market in 2024; Asia-Pacific to grow rapidly post-2024. 5. Pfizer Inc. listed among competitive players in the peri-implantitis market.